FIELD: organic chemistry, medicine, chemical-pharmaceutical industry, pharmacy.
SUBSTANCE: invention relates to a pharmaceutical composition comprising S-isomer of compound of the formula (I) 
or its pharmaceutically acceptable salts and solvates in common with a pharmaceutically acceptable vehicle. Also, invention relates to a method for synthesis of compound S-isomer of the formula (I), and to a method for treatment of disease relating to the group comprising respiratory diseases, allergic diseases, dermatological diseases, gastroenteric diseases and ophthalmic diseases. The composition provides avoiding adverse sedative effects in treatment of indicated diseases.
EFFECT: valuable medicinal properties of compounds.
14 cl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BENZOCYCLOHEPTATHIOPHENE COMPOUNDS, METHODS OF PROPHYLAXIS OR TREATMENT, PHARMACEUTICAL COMPOSITION | 1998 |
|
RU2193557C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PATIENTS WITH ALLERGIC DISEASES, METHOD OF ANTIHISTAMINE TREATMENT, USE OF COMPOSITION FOR DRUG PREPARING | 1993 |
|
RU2167657C2 |
| THERAPEUTIC AGENTS | 2008 |
|
RU2468025C2 |
| COMPOSITIONS CONTAINING MONOAMINE REUPTAKE INHIBITOR AND METHODS OF THEIR APPLICATION | 2004 |
|
RU2358719C2 |
| COMPOSITIONS COMPRISING INHIBITORS OF DOPAMINE RE-UPTAKE AND METHODS FOR THEIR USING | 1999 |
|
RU2238084C2 |
| IMIDAZOLE DERIVATIVES ACTIVE TO CB1 RECEPTOR | 2005 |
|
RU2377238C2 |
| ISOINDOLINONE INHIBITORS OF MDM2-P53 INTERACTION WITH ANTI-CANCER ACTIVITY | 2016 |
|
RU2794333C1 |
| -E-10-OH-NT COMPOSITIONS AND METHOD FOR SYNTHESIS AND USE THEREOF | 2008 |
|
RU2469715C2 |
| 3,3-DIFLUOROPIPERIDINE CARBAMATE HETEROCYCLIC COMPOUNDS AS NR2B NMDA RECEPTOR ANTAGONISTS | 2016 |
|
RU2735277C2 |
| PHARMACEUTICAL COMPOSITIONS | 2011 |
|
RU2568882C2 |
